EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, RadNet's enterprise value is $6,787 Mil.
RadNet's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $1,773 Mil. Therefore, RadNet's EV-to-Revenue for today is 3.83.
The historical rank and industry rank for RadNet's EV-to-Revenue or its related term are showing as below:
RDNT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.98 Med: 1.81 Max: 4.16
Current: 3.83
During the past 13 years, the highest EV-to-Revenue of RadNet was 4.16. The lowest was 0.98. And the median was 1.81.
RDNT's EV-to-Revenue is ranked worse than 58.99% of 217
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.01
vs RDNT: 3.83
As of today (2024-12-15), RadNet's stock price is $78.34.
RadNet's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $24.72. Therefore, RadNet's PS Ratio for today is 3.17.
RadNet EV-to-Revenue Historical Data
The historical data trend for RadNet's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, RadNet's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RadNet's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where RadNet's EV-to-Revenue falls into.
RadNet's current Enterprise Value is $6,787 Mil.
RadNet's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,773 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RadNet's share price for today is $78.34.
RadNet's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.72.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RadNet EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of RadNet's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RDNT has been successfully added to your 